{"id":449,"date":"2024-10-03T10:31:34","date_gmt":"2024-10-03T10:31:34","guid":{"rendered":"https:\/\/sites.exeter.ac.uk\/dexacell\/?page_id=449"},"modified":"2025-12-01T12:16:17","modified_gmt":"2025-12-01T12:16:17","slug":"home","status":"publish","type":"page","link":"https:\/\/sites.exeter.ac.uk\/dexacell\/","title":{"rendered":"Home"},"content":{"rendered":"
\n
\"\"<\/figure><\/div>\n\n\n

DEXACELL is a randomised controlled trial investigating dexamethasone as an adjunctive therapy for the management of cellulitis in urgent secondary care.<\/strong><\/h2>\n\n\n\n

DEXACELL is funded by the NIHR-HTA<\/a>, sponsored by North Bristol NHS Trust<\/a>, and managed by the Exeter Clinical Trials Unit.<\/a> The views expressed on this site are those of the author(s) and not necessarily those of the sponsor or funders.<\/p>\n\n\n\n

Where can you find more information?<\/strong>
Please feel free to explore this site for more information about the trial and trial team, relevant media and publications as well as contact details for further support.<\/p>\n\n\n\n

Please note, recruitment into this trial has now closed.<\/p>\n","protected":false},"excerpt":{"rendered":"

DEXACELL is a randomised controlled trial investigating dexamethasone as an adjunctive therapy for the management of cellulitis in urgent secondary care. DEXACELL is funded by the NIHR-HTA, sponsored by North Bristol NHS Trust, and managed by the Exeter Clinical Trials Unit. The views expressed on this site are those of the author(s) and not necessarily […]<\/p>\n","protected":false},"author":1843,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"acf":[],"yoast_head":"\nHome - The DEXACELL Trial<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sites.exeter.ac.uk\/dexacell\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Home - The DEXACELL Trial\" \/>\n<meta property=\"og:description\" content=\"DEXACELL is a randomised controlled trial investigating dexamethasone as an adjunctive therapy for the management of cellulitis in urgent secondary care. DEXACELL is funded by the NIHR-HTA, sponsored by North Bristol NHS Trust, and managed by the Exeter Clinical Trials Unit. The views expressed on this site are those of the author(s) and not necessarily […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sites.exeter.ac.uk\/dexacell\/\" \/>\n<meta property=\"og:site_name\" content=\"The DEXACELL Trial\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-01T12:16:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-content\/uploads\/sites\/453\/2024\/05\/DEXACELL-Logo.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/\",\"url\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/\",\"name\":\"Home - The DEXACELL Trial\",\"isPartOf\":{\"@id\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-content\/uploads\/sites\/453\/2024\/05\/DEXACELL-Logo.jpg\",\"datePublished\":\"2024-10-03T10:31:34+00:00\",\"dateModified\":\"2025-12-01T12:16:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sites.exeter.ac.uk\/dexacell\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/#primaryimage\",\"url\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-content\/uploads\/sites\/453\/2024\/05\/DEXACELL-Logo.jpg\",\"contentUrl\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-content\/uploads\/sites\/453\/2024\/05\/DEXACELL-Logo.jpg\",\"width\":800,\"height\":318},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Home\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/#website\",\"url\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/\",\"name\":\"The DEXACELL Trial\",\"description\":\"(DEXAmethasone in CELLulitis)\",\"publisher\":{\"@id\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/#organization\",\"name\":\"The DEXACELL Trial\",\"url\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-content\/uploads\/sites\/453\/2024\/05\/DEXACELL-Logo.jpg\",\"contentUrl\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-content\/uploads\/sites\/453\/2024\/05\/DEXACELL-Logo.jpg\",\"width\":800,\"height\":318,\"caption\":\"The DEXACELL Trial\"},\"image\":{\"@id\":\"https:\/\/sites.exeter.ac.uk\/dexacell\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Home - The DEXACELL Trial","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sites.exeter.ac.uk\/dexacell\/","og_locale":"en_US","og_type":"article","og_title":"Home - The DEXACELL Trial","og_description":"DEXACELL is a randomised controlled trial investigating dexamethasone as an adjunctive therapy for the management of cellulitis in urgent secondary care. DEXACELL is funded by the NIHR-HTA, sponsored by North Bristol NHS Trust, and managed by the Exeter Clinical Trials Unit. The views expressed on this site are those of the author(s) and not necessarily […]","og_url":"https:\/\/sites.exeter.ac.uk\/dexacell\/","og_site_name":"The DEXACELL Trial","article_modified_time":"2025-12-01T12:16:17+00:00","og_image":[{"url":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-content\/uploads\/sites\/453\/2024\/05\/DEXACELL-Logo.jpg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/sites.exeter.ac.uk\/dexacell\/","url":"https:\/\/sites.exeter.ac.uk\/dexacell\/","name":"Home - The DEXACELL Trial","isPartOf":{"@id":"https:\/\/sites.exeter.ac.uk\/dexacell\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sites.exeter.ac.uk\/dexacell\/#primaryimage"},"image":{"@id":"https:\/\/sites.exeter.ac.uk\/dexacell\/#primaryimage"},"thumbnailUrl":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-content\/uploads\/sites\/453\/2024\/05\/DEXACELL-Logo.jpg","datePublished":"2024-10-03T10:31:34+00:00","dateModified":"2025-12-01T12:16:17+00:00","breadcrumb":{"@id":"https:\/\/sites.exeter.ac.uk\/dexacell\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sites.exeter.ac.uk\/dexacell\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sites.exeter.ac.uk\/dexacell\/#primaryimage","url":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-content\/uploads\/sites\/453\/2024\/05\/DEXACELL-Logo.jpg","contentUrl":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-content\/uploads\/sites\/453\/2024\/05\/DEXACELL-Logo.jpg","width":800,"height":318},{"@type":"BreadcrumbList","@id":"https:\/\/sites.exeter.ac.uk\/dexacell\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/sites.exeter.ac.uk\/dexacell\/"},{"@type":"ListItem","position":2,"name":"Home"}]},{"@type":"WebSite","@id":"https:\/\/sites.exeter.ac.uk\/dexacell\/#website","url":"https:\/\/sites.exeter.ac.uk\/dexacell\/","name":"The DEXACELL Trial","description":"(DEXAmethasone in CELLulitis)","publisher":{"@id":"https:\/\/sites.exeter.ac.uk\/dexacell\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sites.exeter.ac.uk\/dexacell\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/sites.exeter.ac.uk\/dexacell\/#organization","name":"The DEXACELL Trial","url":"https:\/\/sites.exeter.ac.uk\/dexacell\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sites.exeter.ac.uk\/dexacell\/#\/schema\/logo\/image\/","url":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-content\/uploads\/sites\/453\/2024\/05\/DEXACELL-Logo.jpg","contentUrl":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-content\/uploads\/sites\/453\/2024\/05\/DEXACELL-Logo.jpg","width":800,"height":318,"caption":"The DEXACELL Trial"},"image":{"@id":"https:\/\/sites.exeter.ac.uk\/dexacell\/#\/schema\/logo\/image\/"}}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-json\/wp\/v2\/pages\/449"}],"collection":[{"href":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-json\/wp\/v2\/users\/1843"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-json\/wp\/v2\/comments?post=449"}],"version-history":[{"count":4,"href":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-json\/wp\/v2\/pages\/449\/revisions"}],"predecessor-version":[{"id":1211,"href":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-json\/wp\/v2\/pages\/449\/revisions\/1211"}],"wp:attachment":[{"href":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-json\/wp\/v2\/media?parent=449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-json\/wp\/v2\/categories?post=449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sites.exeter.ac.uk\/dexacell\/wp-json\/wp\/v2\/tags?post=449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}